Use of Anthrax Vaccine in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Volume 49

Abstract

These recommendations concern the use of aluminum hydroxide adsorbed cell-free anthrax vaccine (Anthrax Vaccine Adsorbed AVA, BioPort Corporation, Lansing, MI) in the United States for protection against disease caused by Bacillus anthracis. In addition, information is included regarding the use of chemoprophylaxis against B. anthracis.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Dec 15, 2000
Accession Number
ADA395519

Entities

Organizations

  • Centers for Disease Control and Prevention

Tags

DTIC Thesaurus Topics

  • Anti-Bacterial Agents
  • Cells
  • Health Services
  • Medical Personnel
  • Patient Care
  • Preventive Medicine
  • Side Effects
  • Vaccines

Readers

  • Defense Technology Research and Development.
  • Immunology

Technology Areas

  • Biotechnology